open access

Vol 82, No 9 (2011)
ARTICLES
Get Citation

Evaluation of HPV DNA HR assay in females as a marker of recurrent disease following treatment of cervical intraepithelial neoplasia

Katarzyna Mikołajczak, Witold Kędzia, Ryszard Żaba, Wojciech Silny
Ginekol Pol 2011;82(9).

open access

Vol 82, No 9 (2011)
ARTICLES

Abstract

Summary Aim: The basic assumption of the prevention of cervical cancer is to early detect and treat CIN (cervical intraepithelial neoplasia) as well as to prevent recurrence of neoplasia after therapy. This study involved comparison of the cytology test value and determination of HPV (human papilloma virus) DNA in women treated for CIN so as to find a sensitive and specific marker of disease recurrence. Methods: A group of 107 females after CIN treatment underwent 14-month follow-up and regular cytological and molecular evaluations. Results: Based on the follow-up data the recurrence of CIN was found in 9 females who despite effective therapy for the entire follow-up period were HPV positive. Evaluation of value of HR (high risk) - HPV DNA assay used to detect CIN showed its 100% sensitivity. Conclusion: The HR-HPV DNA assay is likely to be a valuable diagnostic tool facilitating more precise detection of recurrent neoplasia risk than cytological test alone.

Abstract

Summary Aim: The basic assumption of the prevention of cervical cancer is to early detect and treat CIN (cervical intraepithelial neoplasia) as well as to prevent recurrence of neoplasia after therapy. This study involved comparison of the cytology test value and determination of HPV (human papilloma virus) DNA in women treated for CIN so as to find a sensitive and specific marker of disease recurrence. Methods: A group of 107 females after CIN treatment underwent 14-month follow-up and regular cytological and molecular evaluations. Results: Based on the follow-up data the recurrence of CIN was found in 9 females who despite effective therapy for the entire follow-up period were HPV positive. Evaluation of value of HR (high risk) - HPV DNA assay used to detect CIN showed its 100% sensitivity. Conclusion: The HR-HPV DNA assay is likely to be a valuable diagnostic tool facilitating more precise detection of recurrent neoplasia risk than cytological test alone.
Get Citation

Keywords

HPV, cervical neoplasia, recurrence of CIN

About this article
Title

Evaluation of HPV DNA HR assay in females as a marker of recurrent disease following treatment of cervical intraepithelial neoplasia

Journal

Ginekologia Polska

Issue

Vol 82, No 9 (2011)

Bibliographic record

Ginekol Pol 2011;82(9).

Keywords

HPV
cervical neoplasia
recurrence of CIN

Authors

Katarzyna Mikołajczak
Witold Kędzia
Ryszard Żaba
Wojciech Silny

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl